日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Uncovering Thyroid Vulnerability to Doxorubicin: Integrative Cellular and in vivo Evidence of Mitochondrial Dysfunction.

揭示甲状腺对阿霉素的易感性：线粒体功能障碍的整合细胞和体内证据。

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S576622
Huang Weiqiang, Wang Yongpan, Wang Hanbing, Chen Rongbing, Gu Haiqing, Yu Shunyan, Bao Ziwei, Luo Li, Sun Da, Zheng Binjiao
细胞生物学
线粒体
免疫/内分泌
发表日期：2026
文献求助 收藏

Analysis of Adverse Drug Reactions of Clofazimine Reported in the FDA Adverse Event Reporting System from 2004 to 2025 Q1

对2004年至2025年第一季度FDA不良事件报告系统中报告的氯法齐明不良反应的分析

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-025-01224-0
Zhang, Ruoyu; Tao, Yunwen; Bao, Ziwei; Zhang, Jianping; Zeng, Lingwu; Fang, Chen; Wu, Meiying
发表日期：2025
文献求助 收藏

IL-22 Alleviates Sepsis-Induced Acute Lung Injury by Inhibiting Epithelial Cell Apoptosis Associated with STAT3 Signalling.

IL-22 通过抑制与 STAT3 信号传导相关的上皮细胞凋亡来减轻脓毒症引起的急性肺损伤

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S496387
Zhu Chiying, Chen Jiabo, Yan Zhengzheng, Wang Fei, Sun Ziqi, Liu Zeyu, Li Ying, Chen Xiaona, Bao Ziwei, Li Quan, Chen Zhixia
信号转导
细胞生物学
Apoptosis
凋亡
发表日期：2025
文献求助 收藏

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis

吡嗪酰胺的药物暴露和敏感性与耐多药结核病患者对吡嗪酰胺敏感的治疗反应相关

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics16010144
Dong, Shulan; Shao, Ge; Davies Forsman, Lina; Wang, Sainan; Wang, Shanshan; Cao, Jiayi; Bao, Ziwei; Bruchfeld, Judith; Alffenaar, Jan-Willem C; Liu, Jia; Hu, Yi; Wu, Meiying
发表日期：2024
文献求助 收藏

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients

贝达喹啉在多重耐药结核病患者中的群体药代动力学和基于模型的剂量评估

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1022090
Shao, Ge; Bao, Ziwei; Davies Forsman, Lina; Paues, Jakob; Werngren, Jim; Niward, Katarina; Schön, Thomas; Bruchfeld, Judith; Alffenaar, Jan-Willem; Hu, Yi
发表日期：2023
文献求助 收藏

Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China

药物暴露和二线药物敏感性与耐多药结核病患者的治疗反应相关：一项中国多中心前瞻性队列研究

期刊:European Respiratory Journal
影响因子:21
doi:10.1183/13993003.01925-2021
Zheng, Xubin; Davies Forsman, Lina; Bao, Ziwei; Xie, Yan; Ning, Zhu; Schön, Thomas; Bruchfeld, Judith; Xu, Biao; Alffenaar, Jan-Willem; Hu, Yi
发表日期：2022
文献求助 收藏

Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis

三方基序蛋白44的表达及其在人类恶性肿瘤中的预后和临床病理价值：一项荟萃分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-020-07014-w
Xiao, Guoliang; Yang, Qiuxi; Bao, Ziwei; Mao, Haixia; Zhang, Yi; Lin, Shibu
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis

不同抗D免疫球蛋白策略在预防胎儿和新生儿Rh溶血病中的临床价值：一项网络荟萃分析

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0230073
Xie, Xiaohui; Fu, Qiurong; Bao, Ziwei; Zhang, Yi; Zhou, Dan
免疫/内分泌
发表日期：2020
文献求助 收藏